AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

QUININE SULFATE

13 registrations across 5 African markets— 12 active

Markets with QUININE SULFATE

Recent registrations

Brand / ProductMarketHolderStatusExpires
Quinine Sulphate 300 mg Tablets
Tablet
🇳🇬NigeriaSavocent Pharma LtdactiveApr 2031
Malacide Tablets_
Tablet
🇳🇬NigeriaChez Resources Pharmaceutical LimitedactiveJul 2030
Osyquine-300 Tablets
Tablet
🇳🇬NigeriaOssy Adamu Pharmaceutical Company LimitedactiveAug 2028
Alpaquine Tablets
Tablet
🇳🇬NigeriaDony-Triumph and Company Nigeria LimitedactiveMay 2028
Timec Quinine Sulphate Tablet
Tablet
🇳🇬NigeriaGreat Timec Pharma Nigeria LimitedactiveFeb 2026
QUINEX 300MG COMPRIME PELLICULE BOITE DE 18🇨🇮Côte d'IvoireNIYA HEALTHCARE PVT. LTDexpiredJan 2021
QUININE SULFATE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaMEDOPHARMactive
QUININE SULFATE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaMEDOPHARMactive
QUININE SULFATE 300MG CP PEL BTE(10 X 10) CIRON DRUGS &
comprimés pelliculés, boîte de
🇲🇬MadagascarCIRON DRUGS &active
Quinine Sulfate Tablets 300 mg
Tablets
🇹🇿TanzaniaS Kant Healthcare Ltdactive
QUININE SULFATE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaMEDOPHARMactive
QUININE SULFATE 300MG CP PEL BTE(10 X 10) CIRON DRUGS &
comprimés pelliculés, boîte de
🇲🇬MadagascarCIRON DRUGS &active
QUININE SULFATE
ORAL SOLID ORDINARY FILM- COATED TABLETS
🇺🇬UgandaMEDOPHARMactive

QUININE SULFATE in Africa — Regulatory Overview

QUININE SULFATE is registered across 5 African markets with 13 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Nigeria, Uganda, Madagascar, Côte d'Ivoire and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 13 registrations, 12 (92%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.